Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Medicine Research Profiles
Home
Profiles
Departments, Divisions and Centers
Research output
Hepatocellular carcinoma in HIV positive patients
G. Nunnari
, M. Berretta
,
M. R. Pinzone
, M. Di Rosa
, S. Berretta
, G. Cunsolo
, M. Malaguarnera
, S. Cosentino
, P. De Paoli
, J. M. Schnell
, B. Cacopardo
Division of Infectious Diseases
Research output
:
Contribution to journal
›
Article
›
peer-review
60
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Hepatocellular carcinoma in HIV positive patients'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hepatocellular Carcinoma
100%
HIV Patients
100%
Highly Active Antiretroviral Therapy (HAART)
40%
Treatment Options
20%
Risk Factors
20%
Hepatitis C Virus
20%
Performance Status
20%
Human Immunodeficiency Virus Type 1 (HIV-1)
20%
Comorbidity
20%
Liver Transplantation
20%
Clinical Course
20%
Therapeutic Potential
20%
Hepatitis B Virus Infection
20%
Cancer Stage
20%
Patient Management
20%
Improved Survival
20%
Natural History
20%
Cancer Disease
20%
Prevention Management
20%
Therapeutic Management
20%
Quality of Life Improvement
20%
HIV-related
20%
Biological Drugs
20%
Chemotherapy Drugs
20%
Virus B
20%
Up-to-date Review
20%
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Human Immunodeficiency Virus
100%
Highly Active Antiretroviral Therapy
28%
Hepatitis C Virus
14%
Malignant Neoplasm
14%
Liver Transplantation
14%
Quality of Life
14%
Disease Course
14%
Hepatitis B
14%
Therapeutic Management
14%
Comorbidity
14%
Hepatocellular Carcinoma
14%
Diseases
14%
Treatment Option
14%
Nursing and Health Professions
Liver Cell Carcinoma
100%
Human Immunodeficiency Virus
100%
Highly Active Antiretroviral Therapy
28%
Hepatitis C
14%
Liver Transplantation
14%
Hepatitis B
14%
Malignant Neoplasm
14%
Disease Course
14%
Therapeutic Management
14%
Comorbidity
14%
Diseases
14%
Quality of Life
14%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
HIV
100%
Malignant Neoplasm
14%
Chemotherapy
14%
Hepatitis B
14%
Disease Course
14%
Hepatitis C Virus
14%
Comorbidity
14%
Diseases
14%